Table of Content

Executive Summary

1 Product Definition
1.1 Inclusion and Exclusion

2 Market Scope
2.1 Scope of the Study
2.2 Key Questions Answered in the Report

3 Research Methodology
3.1 Global Somatic Genetic Testing Market: Research Methodology
3.2 Data Sources
3.2.1 Primary Data Sources
3.2.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Criteria for Company Profiling

4 Market Overview
4.1 Market Definition
4.2 Market Footprint and Growth Potential, $Million, 2019-2030
4.3 Commercialized Assays and Applications
4.4 COVID-19 Impact: Global Somatic Genetic Testing Market

5 Industry Insights
5.1 Overview
5.2 Legal Requirements and Framework in U.S.
5.2.1 FDA Regulation
5.2.2 CMS Regulation
5.3 Legal Requirements and Framework in Europe
5.4 Legal Requirements and Framework in Asia-Pacific
5.4.1 China
5.4.2 Japan
5.5 Reimbursement Analysis

6 Market Dynamics
6.1 Overview
6.2 Iceberg Analysis
6.3 Impact Analysis
6.4 Market Drivers
6.4.1 Global Increase in Cancer Prevalence
6.4.2 Increasing Consumer Awareness for Tailored Cancer Therapy
6.4.3 Decreasing Cost of Sequencing
6.4.4 Increasing Adoption of Inorganic Growth Strategies in the Market
6.5 Market Restraints
6.5.1 Uncertain Reimbursement and Regulatory Policies
6.5.2 Lack of Trained Professionals in the Field of Oncology
6.5.3 Lack of Established Treatment Protocols for High-Valued Cancer Tests in Emerging Economies
6.6 Market Opportunities
6.6.1 Technological Advancements in the Field of Cancer Genomics
6.6.2 Massive Scope for Adoption of NGS-based Somatic Genetic Tests in Emerging Markets

7 Competitive Landscape
7.1 Product Launches and Upgradations
7.2 Product Approvals
7.3 Synergistic Activities
7.4 Acquisitions
7.5 Market Share Analysis, by Company, 2018–2019
7.6 Growth Share Analysis
7.6.1 Growth Share Analysis (by Company)
7.6.2 Growth Share Analysis (by Technology)

8 Global Somatic Genetic Testing Market (by Product Type), $Million, 2019-2030
8.1 Overview
8.2 Products
8.2.1 Kits and Assays
8.2.2 Instruments
8.2.3 Software
8.3 Services

9 Global Somatic Genetic Testing Market (by Sample), $Million, 2019-2030
9.1 Overview
9.2 Tissue-Based
9.3 Blood-Based
9.4 Bone Marrow Aspirates
9.5 Other Samples

10 Global Somatic Genetic Testing Market (by Technology), $Million, 2019-2030
10.1 Overview
10.2 Sequencing
10.2.1 Next-Generation Sequencing (NGS)
10.2.1.1 Sequencing by Synthesis
10.2.1.2 Other Next-Generation Sequencing Technologies
10.2.2 Traditional Sequencing
10.3 Polymerase Chain Reaction (PCR)
10.3.1 Real-Time Polymerase Chain Reaction (RT-PCR)
10.3.2 Digital Polymerase Chain Reaction (dPCR)
10.4 Microarray
10.5 Other Technologies

11 Global Somatic Genetic Testing Market (by Application), $Million, 2019-2030
11.1 Overview
11.2 Solid Tumors
11.2.1 Breast Cancer
11.2.2 Prostate Cancer
11.2.3 Colorectal Cancer (CRC)
11.2.4 Lung Cancer
11.2.5 Liver Cancer
11.2.6 Ovarian Cancer
11.2.7 Other Solid Tumors
11.3 Hematological Malignancies
11.3.1 Leukemia
11.3.2 Lymphoma
11.3.3 Myeloma

12 Global Somatic Genetic Testing Market (by End User), $Million, 2019-2030
12.1 Overview
12.2 Academic and Research Institutions
12.3 Hospitals and Diagnostic Laboratories
12.4 Pharmaceutical and Biotechnology Companies
12.5 Contract Research Organizations (CROs)
12.6 Other End Users

13 Global Somatic Genetic Testing Market (by Region), $Million, 2019-2030
13.1 Overview
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.2.3 North America Somatic Genetic Testing Market (by Application), 2019-2030
13.3 Europe
13.3.1 Germany
13.3.2 U.K.
13.3.3 France
13.3.4 Italy
13.3.5 Spain
13.3.6 Netherlands
13.3.7 Rest-of-Europe
13.3.8 Europe Somatic Genetic Testing Market (by Application), 2019-2030
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 Australia
13.4.5 South Korea
13.4.6 Rest-of-Asia-Pacific
13.4.7 Asia-Pacific Somatic Genetic Testing Market (by Application), 2019-2030
13.5 Latin America
13.5.1 Brazil
13.5.2 Mexico
13.5.3 Rest-of-Latin America
13.5.4 Latin America Somatic Genetic Testing Market (by Application), 2019–2030
13.6 Rest-of-the-World (RoW)

14 Company Profiles
14.1 Overview
14.2 Agilent Technologies, Inc.
14.2.1 Company Overview
14.2.2 Role of Agilent Technologies, Inc. in the Global Somatic Genetic Testing Market
14.2.3 Financials
14.2.4 Key Insights About Financial Health of the Company
14.2.5 SWOT Analysis
14.3 ARUP Laboratories
14.3.1 Company Overview
14.3.2 Role of ARUP Laboratories in the Global Somatic Genetic Testing Market
14.3.3 SWOT Analysis
14.4 ASURAGEN Inc.
14.4.1 Company Overview
14.4.2 Role of ASURAGEN Inc. in the Global Somatic Genetic Testing Market
14.4.3 SWOT Analysis
14.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd
14.5.1 Company Overview
14.5.2 Role of Beijing Genomics Institute (BGI) Genomics Co., Ltd in the Global Somatic Genetic Testing Market
14.5.3 SWOT Analysis
14.6 bioM?rieux S.A.
14.6.1 Company Overview
14.6.2 Role of bioM?rieux S.A. in the Global Somatic Genetic Testing Market
14.6.3 Financials
14.6.4 Key Insights About Financial Health of the Company
14.6.5 SWOT Analysis
14.7 CENTOGENE N.V.
14.7.1 Company Overview
14.7.2 Role of CENTOGENE N.V. in the Global Somatic Genetic Testing Market
14.7.3 Financials
14.7.4 Key Insights About Financial Health of the Company
14.7.5 SWOT Analysis
14.8 CIRCULOGENE Theranostics, LLC
14.8.1 Company Overview
14.8.2 Role of CIRCULOGENE Theranostics, LLC in the Global Somatic Genetic Testing Market
14.8.3 SWOT Analysis
14.9 F. Hoffmann-La Roche Ltd.
14.9.1 Company Overview
14.9.2 Role of F. Hoffmann-La Roche Ltd. in the Global Somatic Genetic Testing Market
14.9.3 Financials
14.9.4 Key Insights About Financial Health of the Company
14.9.5 SWOT Analysis
14.1 Guardant Health, Inc.
14.10.1 Company Overview
14.10.2 Role of Guardant Health, Inc. in the Global Somatic Genetic Testing Market
14.10.3 Financials
14.10.4 SWOT Analysis
14.11 Illumina, Inc.
14.11.1 Company Overview
14.11.2 Role of Illumina, Inc. in the Global Somatic Genetic Testing Market
14.11.3 Financials
14.11.4 Key Insights About Financial Health of the Company
14.11.5 SWOT Analysis
14.12 Invivoscribe, Inc.
14.12.1 Company Overview
14.12.2 Role of Invivoscribe, Inc. in the Global Somatic Genetic Testing Market
14.12.3 SWOT Analysis
14.13 Laboratory Corporation of America Holdings
14.13.1 Company Overview
14.13.2 Role of Laboratory Corporation of America Holdings in the Global Somatic Genetic Testing Market
14.13.3 Financials
14.13.4 SWOT Analysis
14.14 Mission Bio
14.14.1 Company Overview
14.14.2 Role of Mission Bio in the Global Somatic Genetic Testing Market
14.14.3 SWOT Analysis
14.15 NeoGenomics Laboratories, Inc.
14.15.1 Company Overview
14.15.2 Role of NeoGenomics Laboratories, Inc. in the Global Somatic Genetic Testing Market
14.15.3 Financials
14.15.4 Key Insights about Financial Health of the Company
14.15.5 SWOT Analysis
14.16 OmniSeq
14.16.1 Company Overview
14.16.2 Role of Omniseq in the Global Somatic Genetic Testing Market
14.16.3 SWOT Analysis
14.17 Oxford Nanopore Technologies Ltd.
14.17.1 Company Overview
14.17.2 Role of Oxford Nanopore Technologies Ltd. in the Global Somatic Genetic Testing Market
14.17.3 SWOT Analysis
14.18 Pacific Biosciences of California, Inc.
14.18.1 Company Overview
14.18.2 Role of Pacific Biosciences of California, Inc. in the Global Somatic Genetic Testing Market
14.18.3 Financials
14.18.4 Key Insights About Financial Health of the Company
14.18.5 SWOT Analysis
14.19 QIAGEN N.V.
14.19.1 Company Overview
14.19.2 Role of QIAGEN N.V. in the Global Somatic Genetic Testing Market
14.19.3 Financials
14.19.4 Key Insights about Financial Health of the Company
14.19.5 SWOT Analysis
14.2 Quest Diagnostics Incorporated
14.20.1 Company Overview
14.20.2 Role of Quest Diagnostics Incorporated in the Global Somatic Genetic Testing Market
14.20.3 Financials
14.20.4 SWOT Analysis
14.21 Thermo Fisher Scientific Inc.
14.21.1 Company Overview
14.21.2 Role of Thermo Fisher Scientific Inc. in the Global Somatic Genetic Testing Market
14.21.3 Financials
14.21.4 Key Insights about Financial Health of the Company
14.21.5 SWOT Analysis
 



List of Tables


Table 4.1: Key Somatic Genetic Testing Assays
Table 5.1: Key Coverage Providers for Somatic Genetic Testing
Table 6.1: Likert Scale
Table 6.2: Impact Analysis of Market Drivers
Table 6.3: Impact Analysis of Market Restraints
Table 8.1: Kits and Assays Offered by Key Players
Table 8.2: Instruments Offered by Key Players
Table 8.3: Software Offered by Key Players
Table 8.4: Services Offered by Key Players
Table 11.1: Somatic Genetic Testing Products for Breast Cancer
Table 11.2: Somatic Genetic Testing Products for Breast Cancer
Table 11.3: Somatic Genetic Testing Products for Prostate Cancer
Table 11.4: Somatic Genetic Testing Products for Breast Cancer
Table 11.5: Somatic Genetic Testing Products for Colorectal Cancer
Table 11.6: Somatic Genetic Testing Products for Colorectal Cancer
Table 11.7: Somatic Genetic Testing Products for Lung Cancer
Table 11.8: Somatic Genetic Testing Products for Lung Cancer
Table 11.9: Somatic Genetic Testing Products for Liver Cancer
Table 11.10: Somatic Genetic Testing Products for Liver Cancer
Table 11.11: Somatic Genetic Testing Products for Ovarian Cancer
Table 11.12: Somatic Genetic Testing Products for Ovarian Cancer
Table 11.13: Somatic Genetic Testing Products for Leukemia
Table 11.14: Somatic Genetic Testing Products for Leukemia
Table 11.15: Somatic Genetic Testing Products for Lymphoma
Table 11.16: Somatic Genetic Testing Products for Lymphoma

List of Figures


Figure 1: National Cancer Institute (NCI) of the U.S., Fiscal Budget Year-on-Year, 2013-2018
Figure 2: Impact Analysis of Market Drivers and Market Challenges on Global Somatic Genetic Testing Market
Figure 3: Global Somatic Genetic Testing Market (by Product Type), $Million, 2019 Vs. 2030
Figure 4: Global Somatic Genetic Testing Market (by Sample), $Million, 2019 Vs. 2030
Figure 5: Global Somatic Genetic Testing Market (by Technology), $Million, 2019 vs. 2030
Figure 6: Global Somatic Genetic Testing Market (by Application), $Million, 2019 vs. 2030
Figure 7: Global Somatic Genetic Testing Market (by End User), $Million, 2019 vs. 2030
Figure 8: Global Somatic Genetic Testing: Market Snapshot
Figure 2.1: Global Somatic Genetic Testing, Market Segmentation
Figure 3.1: Global Somatic Genetic Testing Market: Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Global Somatic Genetic Testing Market, $Million, 2019-2030
Figure 4.2: Global Somatic Genetic Testing Market: COVID-19 Impact
Figure 6.1: Iceberg Analysis – Global Somatic Genetic Testing Market
Figure 6.2: Global Cancer Burden, 2018
Figure 6.3: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 6.4: Synergistic Activities, FY2019-FY2020
Figure 7.1: Share of Key Developments and Strategies, January 2018–December 2020
Figure 7.2: Share of Product Launched and Upgradations (by Company), January 2018–December 2020
Figure 7.3: Share of Product Approvals (by Company), January 2018-December 2020
Figure 7.4: Share of Synergistic Activities (by Company), January 2018- December 2020
Figure 7.5: Share of Acquisitions (by Company), January 2018-December 2020
Figure 7.6: Market Share Analysis for Global Somatic Genetic Testing Market, 2018 and 2019
Figure 7.7: Growth Share Analysis for Global Somatic Genetic Testing Market (by Company), 2019
Figure 7.8: Growth Share Analysis for Global Somatic Genetic Testing Market (by Technology), 2019-2030
Figure 8.1: Global Somatic Genetic Testing Market (by Product Type)
Figure 8.2: Global Somatic Genetic Testing Market (by Product Type), 2019-2030
Figure 8.3: Global Somatic Genetic Testing Market (by Product), $Million, 2019-2030
Figure 8.4: Global Somatic Genetic Testing Market (by Products), 2019 and 2030
Figure 8.5: Global Somatic Genetic Testing Market (Kits and Assays), $Million, 2019-2030
Figure 8.6: Global Somatic Genetic Testing Market (Instruments), $Million, 2019-2030
Figure 8.7: Global Somatic Genetic Testing Market (Software), $Million, 2019-2030
Figure 8.8: Global Somatic Genetic Testing Market (Services), $Million, 2019-2030
Figure 9.1: Global Somatic Genetic Testing Market (by Sample), $Million, 2019-2030
Figure 9.2: Global Somatic Genetic Testing Market (by Sample), 2019 and 2030
Figure 9.3: Global Somatic Genetic Testing Market (Tissue-Based), $Million, 2019-2030
Figure 9.4: Global Somatic Genetic Testing Market (Blood-Based), $Million, 2019-2030
Figure 9.5: Global Somatic Genetic Testing Market (Bone Marrow Aspirates), $Million, 2019-2030
Figure 9.6: Global Somatic Genetic Testing Market (Other Samples), $Million, 2019-2030
Figure 10.1: Global Somatic Genetic Testing Market (by Technology)
Figure 10.2: Global Somatic Genetic Testing Market (by Technology), 2019 and 2030
Figure 10.3: Global Somatic Genetic Testing Market (by Sequencing), $Million, 2019-2030
Figure 10.4: Global Somatic Genetic Testing Market (by Sequencing), 2019 and 2030
Figure 10.5: Global Somatic Genetic Testing Market (by NGS), $Million, 2019-2030
Figure 10.6: Global Somatic Genetic Testing Market (by NGS), 2019 and 2030
Figure 10.7: Global Somatic Genetic Testing Market (SBS), $Million, 2019-2030
Figure 10.8: Global Somatic Genetic Testing Market (Other Next-Generation Sequencing Technologies), $Million, 2019-2030
Figure 10.9: Global Somatic Genetic Testing Market (Traditional Sequencing), $Million, 2019-2030
Figure 10.10: Global Somatic Genetic Testing Market (by PCR), $Million, 2019-2030
Figure 10.11: Global Somatic Genetic Testing Market (by PCR), 2019 and 2030
Figure 10.12: Global Somatic Genetic Testing Market (RT-PCR), $Million, 2019-2030
Figure 10.13: Global Somatic Genetic Testing Market (dPCR), $Million, 2019-2030
Figure 10.14: Global Somatic Genetic Testing Market (Microarray), $Million, 2019-2030
Figure 10.15: Global Somatic Genetic Testing Market (Other Technologies), $Million, 2019-2030
Figure 11.1: Global Somatic Genetic Testing Market (by Application)
Figure 11.2: Global Somatic Genetic Testing Market (by Application), $Million, 2019-2030
Figure 11.3: Global Somatic Genetic Testing Market (by Solid Tumors), $Million, 2019-2030
Figure 11.3: Global Somatic Genetic Testing Market (by Solid Tumors), 2019 and 2030
Figure 11.4: Global Prevalence of Breast Cancer, (2014–2019)
Figure 11.5: Global Somatic Genetic Testing Market (Breast Cancer), $Million, 2019-2030
Figure 11.6: Global Prevalence of Prostate Cancer, (2014-2019)
Figure 11.7: Global Somatic Genetic Testing Market (Prostate Cancer), $Million, 2019-2030
Figure 11.8: Global Prevalence of Colorectal Cancer (2014-2019)
Figure 11.9: Global Somatic Genetic Testing Market (Colorectal Cancer), $Million, 2019-2030
Figure 11.10: Global Prevalence of Lung Cancer (2014-2019)
Figure 11.11: Global Somatic Genetic Testing Market (Lung Cancer), $Million, 2019-2030
Figure 11.12: Global Prevalence of Liver Cancer (2014-2019)
Figure 11.13: Global Somatic Genetic Testing Market (Liver Cancer), $Million, 2019-2030
Figure 11.14: Global Prevalence of Ovarian Cancer (2014-2019)
Figure 11.15: Global Somatic Genetic Testing Market (Ovarian Cancer), $Million, 2019-2030
Figure 11.16: Global Somatic Genetic Testing Market (Other Solid Tumors), $Million, 2019-2030
Figure 11.17: Global Somatic Genetic Testing Market (by Hematological Malignancies), $Million, 2019-2030
Figure 11.18: Global Somatic Genetic Testing Market (by Hematological Malignancies), 2019 and 2030
Figure 11.19: Global Prevalence of Leukemia, (2014-2019)
Figure 11.20: Global Somatic Genetic Testing Market (Leukemia), $Million, 2019-2030
Figure 11.21: Global Prevalence of Lymphoma (2014-2019)
Figure 11.22: Global Somatic Genetic Testing Market (Lymphoma), $Million, 2019-2030
Figure 11.23: Global Prevalence of Myeloma (2014-2019)
Figure 11.24: Global Somatic Genetic Testing Market (Myeloma), $Million, 2019-2030
Figure 12.1: Global Somatic Genetic Testing Market (by End User)
Figure 12.2: Global Somatic Genetic Testing Market (by End User), $Million, 2019-2030
Figure 12.3: Global Somatic Genetic Testing Market (Academic and Research Institutions), $Million, 2019-2030
Figure 12.4: Global Somatic Genetic Testing Market (Hospitals and Diagnostic Laboratories), $Million, 2019-2030
Figure 12.5: Global Somatic Genetic Testing Market (Pharmaceutical and Biotechnology Companies), $Million, 2019-2030
Figure 12.6: Global Somatic Genetic Testing Market (Contract Research Organizations), $Million, 2019-2030
Figure 12.7: Global Somatic Genetic Testing Market (Other End Users), $Million, 2019-2030
Figure 13.1: Global Somatic Genetic Testing Market (by Region)
Figure 13.2: Global Somatic Genetic Testing Market (by Region), $Million, 2019-2030
Figure 13.3: Global Somatic Genetic Testing Market (by Region), 2019-2030
Figure 13.4: North America Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.5: North America: Market Dynamics
Figure 13.6: North America Somatic Genetic Testing Market (by Country), $Million, 2019-2030
Figure 13.7: U.S. Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.8: Canada Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.9: Growth-Share Analysis for North America Somatic Genetic Testing Market (by Application), 2019-2030
Figure 13.10: Europe Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.11: Europe: Market Dynamics
Figure 13.12: Europe Somatic Genetic Testing Market (by Country), $Million, 2019-2030
Figure 13.13: Germany Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.14: U.K. Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.15: France Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.16: Italy Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.17: Spain Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.18: Netherlands Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.19: Rest-of-Europe Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.20: Growth-Share Analysis for Europe Somatic Genetic Testing Market (by Application), 2019-2030
Figure 13.21: Asia-Pacific Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.22: APAC: Market Dynamics
Figure 13.23: APAC Somatic Genetic Testing Market (by Country), $Million, 2019-2030
Figure 13.24: China Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.25: Japan Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.26: India Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.27: Australia Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.28: South Korea Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.29: RoAPAC Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.30: Growth-Share Analysis for Asia-Pacific Somatic Genetic Testing Market (by Application), 2019-2030
Figure 13.31: Latin America Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.32: Latin America: Market Dynamics
Figure 13.33: Latin America Somatic Genetic Testing Market (by Country), $Million, 2019-2030
Figure 13.34: Brazil Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.35: Mexico Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.36: Rest-of-Latin America Somatic Genetic Testing Market, $Million, 2019-2030
Figure 13.37: Growth-Share Analysis for Latin America Somatic Genetic Testing Market (by Application), 2019-2030
Figure 13.38: RoW Somatic Genetic Testing Market, $Million, 2019-2030
Figure 14.1: Total Number of Companies Profiled
Figure 14.2: Agilent Technologies, Inc.: Product Portfolio
Figure 14.3: Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 14.4: Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
Figure 14.5: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 14.6: Agilent Technologies, Inc.: R&D Expenditure, 2017-2019
Figure 14.7: Agilent Technologies, Inc.: SWOT Analysis
Figure 14.8: ARUP Laboratories: Product Portfolio
Figure 14.9: ARUP Laboratories: SWOT Analysis
Figure: ASURAGEN, Inc.: Product Portfolio
Figure 14.10: ASURAGEN, Inc.: SWOT Analysis
Figure 14.11: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Product Portfolio
Figure 14.12: Beijing Genomics Institute (BGI) Genomics Co., Ltd.: SWOT Analysis
Figure 14.13: bioM?rieux S.A.: Product Portfolio
Figure 14.14: bioM?rieux S.A.: Overall Financials, 2017-2019
Figure 14.15: bioM?rieux S.A.: Revenue (by Segment), 2017-2019
Figure 14.16: bioM?rieux S.A.: Revenue (by Region), 2017-2019
Figure 14.17: bioM?rieux S.A.: R&D Expenditure, 2017-2019
Figure 14.18: bioM?rieux S.A.: SWOT Analysis
Figure 14.19: CENTOGENE N.V.: Portfolio
Figure 14.20: CENTOGENE N.V.: Overall Financials, 2018-2020
Figure 14.21: CENTOGENE N.V.: Sales (by Segment), 2017-2019
Figure 14.22: CENTOGENE N.V.: Revenue (by Region), 2017-2019
Figure 14.23: CENTOGENE N.V.: R&D Expenditure, 2017-2019
Figure 14.24: CENTOGENE N.V.: SWOT Analysis
Figure 14.25: CIRCULOGENE Theranostics, LLC: Portfolio
Figure 14.26: CIRCULOGENE Theranostics, LLC: SWOT Analysis
Figure 14.27: F. Hoffmann-La Roche Ltd.: Portfolio
Figure 14.28: F. Hoffmann-La Roche Ltd.: Overall Financials, 2018-2020
Figure 14.29: F. Hoffmann-La Roche Ltd.: Sales (by Segment), 2018-2020
Figure 14.30: F. Hoffmann-La Roche Ltd.: Sales (by Diagnostics), 2018-2020
Figure 14.31: F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2018-2020
Figure 14.32: F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2018-2020
Figure 14.33: F. Hoffmann-La Roche Ltd.: SWOT Analysis
Figure 14.34: Guardant Health, Inc.: Portfolio
Figure 14.35: Guardant Health, Inc.: Overall Financials, 2017-2019
Figure 14.36: Guardant Health, Inc.: Revenue (by Segment), 2017-2019
Figure 14.37: Guardant Health, Inc.: Revenue (by Region), 2017-2019
Figure 14.38: Guardant Health, Inc.: SWOT Analysis
Figure 14.39: Illumina, Inc.: Product Portfolio
Figure 14.40: Illumina, Inc.: Overall Financials, 2017-2019
Figure 14.41: Illumina, Inc.: Revenue (by Segment), 2017-2019
Figure 14.42: Illumina, Inc.: Revenue (by Region), 2017-2019
Figure 14.43: Illumina, Inc.: R&D Expenditure, 2017-2019
Figure 14.44: Illumina, Inc.: SWOT Analysis
Figure 14.45: Invivoscibe, Inc.: Product Portfolio
Figure 14.46: Invivoscibe, Inc.: SWOT Analysis
Figure 14.47: Laboratory Corporation of America Holdings: Product Portfolio
Figure 14.48: Laboratory Corporation of America Holdings: Overall Financials, 2017-2019
Figure 14.49: Laboratory Corporation of America Holdings: Revenue (by Segment), 2017-2019
Figure 14.50: Laboratory Corporation of America Holdings: Revenue (by Region), 2019
Figure 14.51: Laboratory Corporation of America Holdings: SWOT Analysis
Figure 14.52: Mission Bio: Product Portfolio
Figure 14.53: Mission Bio: SWOT Analysis
Figure 14.54: NeoGenomics Laboratories, Inc.: Portfolio
Figure 14.55: NeoGenomics Laboratories, Inc.: Overall Financials, 2017-2019
Figure 14.56: NeoGenomics Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 14.57: NeoGenomics Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 14.58: NeoGenomics Laboratories, Inc.: SWOT Analysis
Figure 14.59: OmniSeq: Portfolio
Figure 14.60: OmniSeq: SWOT Analysis
Figure 14.61: Oxford Nanopore Technologies Ltd.: Product Portfolio
Figure 14.62: Oxford Nanopore Technologies Ltd..: SWOT Analysis
Figure 14.63: Pacific Biosciences of California, Inc.: Product Portfolio
Figure 14.64: Pacific Biosciences of California, Inc.: Overall Financials, 2017-2019
Figure 14.65: Pacific Biosciences of California, Inc.: Revenue (by Segment), 2017-2019
Figure 14.66: Pacific Biosciences of California, Inc.: Revenue (by Region), 2017-2019
Figure 14.67: Pacific Biosciences of California, Inc.: R&D Expenditure, 2017-2019
Figure 14.68: Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 14.69: QIAGEN N.V.: Product Portfolio
Figure 14.70: QIAGEN N.V.: Overall Financials, 2017-2019
Figure 14.71: QIAGEN N.V.: Revenue (by Segment), 2017-2019
Figure 14.72: QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 14.73: QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 14.74: QIAGEN N.V.: SWOT Analysis
Figure 14.75: Quest Diagnostics Incorporated: Portfolio
Figure 14.76: Quest Diagnostics Incorporated: Overall Financials, 2017-2019
Figure 14.77: Quest Diagnostics Incorporated: Revenue (by Segment), 2017-2019
Figure 14.78: Quest Diagnostics Incorporated: SWOT Analysis
Figure 14.79: Thermo Fisher Scientific, Inc.: Product Portfolio
Figure 14.80: Thermo Fisher Scientific, Inc.: Overall Financials, 2017-2019
Figure 14.81: Thermo Fisher Scientific Inc.: Sales (by Segment): 2017-2020
Figure 14.82: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 14.83: Thermo Fisher Scientific Inc.: R&D Expenditure, 2017-2019
Figure 14.84: Thermo Fisher Scientific Inc.: SWOT Analysis